Marker Therapeutics grants 50,000 CEO options and 30,000 options each to three non-employee directors

Marker Therapeutics, Inc.

CEO Juan Vera awarded 50,000 stock options vesting annually over three years under 2020 Plan.
Non-employee directors David Eansor, Katherine Knobil, and Steven Elms each receive 30,000 options with same vesting.
Awards approved by Compensation Committee and Board on February 12, 2024.

item 5.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-015224
form_type: 8-K
ticker: MRKR
cik: 0001094038
company_name: Marker Therapeutics, Inc.
filed_at: 2025-02-19T23:59:59+00:00
discovered_at: 2026-05-14T18:03:02.912752+00:00
generated_at: 2026-05-26T10:26:58.864534+00:00
sec_items: ["5.02", "8.01", "9.01"]
event_type: other
sentiment: neutral
materiality_score: 0.2
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-015224
json_url: https://secwatch.observer/filing/0001104659-25-015224.json
markdown_url: https://secwatch.observer/filing/0001104659-25-015224.md
text_url: https://secwatch.observer/filing/0001104659-25-015224.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1094038/000110465925015224/0001104659-25-015224-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1094038/000110465925015224/tm257101d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-25-015224

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.